NSRX

Nasus Pharma
NSRX

2.56 USD
-0.35
12.03%
At close Updated Apr 29, 4:00 PM EDT
Pre-market
After hours
2.50
-0.06
2.34%
1 day
-12.03%
5 days
-42.98%
1 month
27.36%
3 months
-54.2%
6 months
-66.97%
Year to date
-66.09%
1 year
-68.97%
5 years
-68.97%
10 years
-68.97%
 

About: Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Employees: 7

Healthcare Drug Manufacturers - General
0
Funds holding %
of 8,127 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™